Fresenius Kabi Oncology Ltd
ISIN: INE575G01010 | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE 143.30 14.55 [11.30%]
NSE 143.40 14.50 [11.25%]
BSE : May 24, 07:32
| Open Price |
130.80 |
Shares Traded |
272040 |
| High Price |
145.45 |
52 Wk High |
176.00 |
| Low Price |
130.80 |
52 Wk Low |
81.65 |
| Previous Close |
128.75 |
Face Value |
1.00 |
| 52 Wk High Date |
17-04-2012 |
52 Wk Low Date |
20-12-2011 |
NSE : May 24, 07:32
| Open Price |
133.00 |
Shares Traded |
122610 |
| High Price |
145.50 |
52 Wk High |
175.75 |
| Low Price |
132.50 |
52 Wk Low |
81.30 |
| Previous Close |
128.90 |
Face Value |
1.00 |
| 52 Wk High Date |
16-04-2012 |
52 Wk Low Date |
20-12-2011 |
| Key Financials |
Latest Qrtr. |
Trailing Yr. |
Full Yr. |
| Year End |
Dec, 2011 |
Dec, 2011 |
Mar, 2011 |
| Sales (Rs.cr) |
110.67 |
453.12 |
402.14 |
| Net Profit (Rs.cr) |
2.75 |
25.47 |
47.57 |
| Net Profit Var (%) |
-43.00 |
-54.00 |
-29.00 |
| EPS (Rs) |
- |
|
3.00 |
| P/E Ratio |
- |
80.12 |
42.90 |
| Operating Profit Margin |
- |
11.82 |
- |
| CPS (Rs.) |
- |
- |
4.10 |
| P/C Ratio |
- |
- |
31.60 |
| Div% |
- |
- |
- |
| Fundamentals |
| Market Capital (Rs.cr) |
2036.83 |
| EPS (Rs.)(TTM) |
|
| P/E Ratio(TTM) |
80.12 |
| Book Value (Rs.) |
34.20 |
| Price to Book Value |
3.77 |
| Equity (Rs.cr.) |
15.82 |
| Traded Value (Rs.lac) |
82.61 |
| Announcements |
| 27-05-2011 |
Fresenius Kabi Oncology to focus on contract R D and manufacturing activities |
| Gross Deliverables |
| Date |
Del. Shares |
Trd. Qty. |
Del.(%) |
Del. Value |
Turnover |
| 15-05-2012 |
14932 |
29090 |
51.33 |
1814985 |
3,607.94 |
| 11-05-2012 |
13232 |
27716 |
47.74 |
1732730 |
3,620.49 |
| 09-05-2012 |
9828 |
25983 |
37.82 |
1334642 |
3,573.03 |
| 08-05-2012 |
25394 |
67898 |
37.40 |
3470090 |
9,568.85 |
| 04-05-2012 |
26944 |
44373 |
60.72 |
3716925 |
6,233.91 |
